These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 7915991)
21. Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications. Braun AR; Laruelle M; Mouradian MM J Neural Transm (Vienna); 1997; 104(4-5):341-62. PubMed ID: 9295170 [TBL] [Abstract][Full Text] [Related]
22. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation. Carvey PM; Hitri A; Goetz CG; Tanner CM; Klawans HL Life Sci; 1988; 42(22):2207-15. PubMed ID: 3374255 [TBL] [Abstract][Full Text] [Related]
23. Brexpiprazole has a low risk of dopamine D Amada N; Akazawa H; Ohgi Y; Maeda K; Sugino H; Kurahashi N; Kikuchi T; Futamura T Neuropsychopharmacol Rep; 2019 Dec; 39(4):279-288. PubMed ID: 31487433 [TBL] [Abstract][Full Text] [Related]
24. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies. Hu XT; White FJ Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772 [TBL] [Abstract][Full Text] [Related]
25. Delayed inhibition of dopamine synthesis by gamma-butyrolactone and baclofen: dopamine autoreceptor supersensitivity? Argiolas A; Fadda F; Melis MR; Marcou M; Porceddu ML; Gessa GL Eur J Pharmacol; 1982 Nov; 85(1):23-7. PubMed ID: 6818043 [TBL] [Abstract][Full Text] [Related]
26. Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigm. Carvey PM; Nath ST; Kao LC; Zhang TJ; Lin DH; Singh R; Amdur RL; Klawans HL Eur J Pharmacol; 1990 Aug; 184(1):43-53. PubMed ID: 2209714 [TBL] [Abstract][Full Text] [Related]
27. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related]
28. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats. Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034 [TBL] [Abstract][Full Text] [Related]
29. Molindone compared to haloperidol in a guinea-pig model of tardive dyskinesia. Koller W; Curtin J; Fields J Neuropharmacology; 1984 Oct; 23(10):1191-4. PubMed ID: 6240609 [TBL] [Abstract][Full Text] [Related]
30. Permanent haloperidol-induced dopamine receptor up-regulation in the ovariectomized rat. Fields JZ; Gordon JH Brain Res Bull; 1991 Apr; 26(4):549-52. PubMed ID: 1831063 [TBL] [Abstract][Full Text] [Related]
31. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity. Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634 [TBL] [Abstract][Full Text] [Related]
32. Effect of chronic haloperidol and quinacrine coadministration on striatal HVA levels and stereotypic behaviors in response to apomorphine in the rat. Deutsch SI; Halperin R; Stanley M; Davis KL Neurochem Res; 1985 Apr; 10(4):491-8. PubMed ID: 2582289 [TBL] [Abstract][Full Text] [Related]
33. Effects of serotonergic agents on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum. Ishikane T; Kusumi I; Matsubara R; Matsubara S; Koyama T Eur J Pharmacol; 1997 Feb; 321(2):163-9. PubMed ID: 9063684 [TBL] [Abstract][Full Text] [Related]
34. Effects of pertussis toxin on D2-dopamine receptor in rat striatum: evidence for coupling of Ni regulatory protein with D2-receptor. Fujita N; Nakahiro M; Fukuchi I; Saito K; Yoshida H Brain Res; 1985 May; 333(2):231-6. PubMed ID: 3158374 [TBL] [Abstract][Full Text] [Related]
35. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol. Hashimoto T; Baba S; Ikeda H; Oda Y; Hashimoto K; Shimizu I Eur J Pharmacol; 2018 Jul; 830():26-32. PubMed ID: 29684390 [TBL] [Abstract][Full Text] [Related]
36. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist. Nisoli E; Tonello C; Imhof R; Scherschlicht R; da Prada M; Carruba MO J Pharmacol Exp Ther; 1993 Jul; 266(1):97-105. PubMed ID: 8101225 [TBL] [Abstract][Full Text] [Related]
38. Involvement of dopamine D2 and 5-HT1A receptors in roxindole-induced antinociception. Ninan I; Kulkarni SK Indian J Exp Biol; 1999 Mar; 37(3):234-7. PubMed ID: 10641151 [TBL] [Abstract][Full Text] [Related]
39. Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity. Pert A; Rosenblatt JE; Sivit C; Pert CB; Bunney WE Science; 1978 Jul; 201(4351):171-3. PubMed ID: 566468 [TBL] [Abstract][Full Text] [Related]
40. The effect of LSD and 2-bromo LSD on the striatal DOPA accumulation after decarboxylase inhibition in rats. Persson SA Eur J Pharmacol; 1977 May; 43(1):73-83. PubMed ID: 16756 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]